Non-alcoholic fatty liver disease, metabolic goal achievement with incident cardiovascular disease and eGFR-based chronic kidney disease in patients with prediabetes and diabetes-Reference-Cited by-同舟云学术

Non-alcoholic fatty liver disease, metabolic goal achievement with incident cardiovascular disease and eGFR-based chronic kidney disease in patients with prediabetes and diabetes

Published:2021-11 Issue: Volume:124 Page:154874
ISSN:0026-0495
Container-title:Metabolism
language:en
Short-container-title:Metabolism

Author:

Li Mian,Zhao Zhiyun,Qin Guijun,Chen Li,Lu Jieli,Huo Yanan,Chen Lulu,Zeng Tianshu,Xu Min,Chen Yuhong,Wang Tiange,Wang Shuangyuan,Xu Yiping,Shi Lixin,Tang Xulei,Su Qing,Yu Xuefeng,Yan Li,Wan Qin,Chen Gang,Gao Zhengnan,Wang Guixia,Shen Feixia,Luo Zuojie,Zhang Yinfei,Liu Chao,Wang Youmin,Hu Ruying,Ye Zhen,Wu Shengli,Deng Huacong,Yang Tao,Li Qiang,Qin Yingfen,Mu Yiming,Zhao Jiajun,Ning Guang,Bi Yufang,Xu Yu,Wang Weiqing

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Reference45 articles.

1. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention;Younossi;Nat Rev Gastroenterol Hepatol,2018

2. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes;Younossi;Hepatology,2016

3. Epidemiological features of NAFLD from 1999 to 2018 in China;Zhou;Hepatology,2020

4. The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis;Younossi;J Hepatol,2019

5. Non-alcoholic fatty liver disease and type 2 diabetes: importance of glycemic control;Bloomgarden;J Diabetes,2017

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of non‐alcoholic fatty liver disease and fibrosis on mortality and kidney outcomes in patients with type 2 diabetes and chronic kidney disease: A multi‐cohort longitudinal study;Diabetes, Obesity and Metabolism;2024-07-18

2. Frail hypertensive older adults with prediabetes and chronic kidney disease: insights on organ damage and cognitive performance - preliminary results from the CARYATID study;Cardiovascular Diabetology;2024-04-10

3. Fatty liver index is an independent risk factor for all-cause mortality and major cardiovascular events in type 1 diabetes: an 11-year observational study;Cardiovascular Diabetology;2024-02-28

4. The effectiveness of oral anti-SARS-CoV-2 agents in non-hospitalized COVID-19 patients with nonalcoholic fatty liver disease: a retrospective study;Frontiers in Pharmacology;2024-02-15

5. Atherogenic Index of Plasma as an Early Marker of Chronic Kidney Disease and Liver Injury in Type 2 Diabetes;Clinical Medicine Insights: Endocrinology and Diabetes;2024-01